The Senior Manager, Market Access Consulting will lead strategic healthcare consulting engagements, helping clients navigate complex payer environments, pricing strategies, and reimbursement challenges.
Compensation
Starting salary of $120,000+, depending on experience and qualifications.
Responsibilities
Oversee client engagements and develop evidence-based market access strategies
Design and execute payer research, pricing, reimbursement, and broader market access engagements
Interpret client objectives and develop tailored approaches using qualitative research, quantitative analysis, secondary data, and strategic advisory expertise
Design and facilitate primary market research with national and regional payers, HTA experts, employers, hospitals, health systems, Integrated Delivery Networks (IDNs), Key Opinion Leaders (KOLs), and other relevant access stakeholders
Synthesize primary and secondary research findings, competitive intelligence, and access considerations into clear strategic insights and actionable client recommendations
Requirements
Bachelor's degree
Master's degree in Life Sciences, Public Health, Health Economics, Healthcare Policy, Business, or a related discipline
Shape and lead the Market Access and Healthcare Affairs strategy of Specialty and Rare diseases product portfolio across the IMETA region.
Responsibilities
Shape and lead the IMETA Market Access strategy for the assigned therapeutic area, translating global direction into regional Pricing, Reimbursement and Enlisting strategies that reflect local payer needs, healthcare systems and market dynamics.
Drive Market Access planning and execution across IMETA, setting clear regional priorities and providing strategic guidance to OPUs on their local Market Access plans, resource allocation, budgets and capabilities.
Accelerate pipeline and launch readiness by identifying future access opportunities and barriers early and designing payer engagement, market-shaping, evidence-generation and reimbursement strategies for new products and indications.
Monitor and shape the evolving healthcare environment, identifying healthcare megatrends, policy developments, access gaps and system changes, and translating these into strategic opportunities and timely recommendations for regional and country leadership.
Lead strategic Pricing, Reimbursement and Value Proposition development, providing guidance on pricing optimization, payer value stories, economic models, value dossiers and national submissions to accelerate and maximize patient access.
Requirements
Bachelor’s degree in Life Sciences/ Economics or Business Administration
Lead, coach, and develop a high‑performing national and regional market access organization to drive payer coverage, reimbursement, and revenue growth.
Responsibilities
Lead, coach, develop, and inspire a high‑performing team of National Directors and Regional Market Access Managers
Establish clear performance expectations, KPIs, and accountability measures aligned to coverage, contracting, reimbursement, and access goals
Conduct regular business reviews, strategic account reviews, and performance coaching sessions
Develop succession plans and leadership pipelines for critical roles
Recruit, retain, and develop top talent while maintaining strong employee engagement
Requirements
Bachelor’s degree in Life Sciences, Business, Healthcare Administration, Public Health, or a related field
Develop and execute strategic payer account plans that expand coverage, contracting, and reimbursement for Baylor Genetics testing, with priority emphasis on WGS-first policies.
Responsibilities
Develop and execute strategic payer account plans that expand coverage, contracting, and reimbursement for Baylor Genetics testing, with priority emphasis on WGS-first policies.
Establish trusted, value-based partnerships with national and regional commercial health plans, Medicare Advantage organizations, Medicaid and Managed Medicaid plans, integrated delivery networks, and other risk-bearing entities.
Lead payer negotiations that translate clinical and economic value into favorable coverage policies, fee schedules, network agreements, value-based arrangements, and administrative pathways.
Create payer-specific value propositions that connect WGS-first testing to improved diagnostic yield, earlier clinical decision-making, reduced serial testing, fewer avoidable procedures, and lower total cost of care.
Partner with HEOR, Medical Affairs, Clinical Affairs, Product, Finance, Revenue Cycle, and Commercial teams to develop evidence strategies, budget-impact models, cost-offset analyses, real-world evidence, and payer-facing value dossiers.
A leadership role in shaping global access, pricing, reimbursement, and evidence strategies for an innovative cell therapy portfolio, serving as a strategic partner to cross-functional asset teams and executive leaders.